Clinical Trial Update: Tosedostat With Capecitabine in Patients With Metastatic Pancreatic Adenocarcinoma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for tosedostat with capecitabine in metastatic pancreatic adenocarcinoma (Phase 1/2); study terminated with posted results in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma
• Pancreatic Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Tosedostat (tosedostat)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Pancreatic Cancer, Cancer of Pancreas | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2018-12-17